These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15845183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
    Li M, Liu N, Hu M, Shi F, Yuan S, Zhang P, Fu Z, Yang G, Yu J.
    Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284
    [Abstract] [Full Text] [Related]

  • 3. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM.
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
    Trister AD, Pryma DA, Xanthopoulos E, Kucharczuk J, Sterman D, Rengan R.
    Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
    [Abstract] [Full Text] [Related]

  • 6. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
    Kaira K, Endo M, Asakura K, Tsuya A, Nakamura Y, Naito T, Murakami H, Takahashi T, Yamamoto N.
    Ann Nucl Med; 2010 Dec; 24(10):697-705. PubMed ID: 20824397
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    Hoang JK, Hoagland LF, Coleman RE, Coan AD, Herndon JE, Patz EF.
    J Clin Oncol; 2008 Mar 20; 26(9):1459-64. PubMed ID: 18349396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ, Akhurst T, Gonen M, Park B, Rusch V.
    J Thorac Cardiovasc Surg; 2007 Jun 20; 133(6):1419-27. PubMed ID: 17532932
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan 20; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy.
    Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R.
    J Radiat Res; 2010 Jan 20; 51(4):465-71. PubMed ID: 20508373
    [Abstract] [Full Text] [Related]

  • 13. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
    Pastorino U, Landoni C, Marchianò A, Calabrò E, Sozzi G, Miceli R, Picchio M, Mariani L, Messa C, Fazio F.
    J Thorac Oncol; 2009 Nov 20; 4(11):1352-6. PubMed ID: 19861905
    [Abstract] [Full Text] [Related]

  • 14. [Positron emission tomography/computed tomography for lung cancer staging].
    Ladrón de Guevara H D, Furnaro L F, Yévenes A S, Clavero R JM, Lazo P D, Rodríguez D P, Piottante B A, Pefaur D R, Pardo B C.
    Rev Med Chil; 2015 Jan 20; 143(1):22-9. PubMed ID: 25860265
    [Abstract] [Full Text] [Related]

  • 15. Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.
    Duan XY, Wang W, Li M, Li Y, Guo YM.
    Braz J Med Biol Res; 2015 Mar 20; 48(3):267-72. PubMed ID: 25651460
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.
    Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu J, Wang Q, Chen G, Chen H, Xiang J, Fu X.
    Lung Cancer; 2013 Aug 20; 81(2):213-7. PubMed ID: 23664030
    [Abstract] [Full Text] [Related]

  • 17. FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.
    Zhu SH, Zhang Y, Yu YH, Fu Z, Kong L, Han DL, Fu L, Yu JM, Li J.
    Asian Pac J Cancer Prev; 2013 Aug 20; 14(5):2925-9. PubMed ID: 23803055
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Aug 20; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 19. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 20; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.
    Prévost S, Boucher L, Larivée P, Boileau R, Bénard F.
    J Nucl Med; 2006 Apr 20; 47(4):559-65. PubMed ID: 16595487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.